[Pulmonary lobectomy in children: the sooner the better?]

P Triana Junco1, C de la Torre1, M I Barrio2

  • 1Servicio de Cirugía Pediátrica. Hospital Universitario La Paz. Madrid.

Insights

Early pulmonary resection for congenital pulmonary airway malformations (CPAMs) may not be beneficial. Surgery after one year of age showed better long-term lung function (FEV1/FVC) compared to early CPAM lobectomy.

Area of Science:

  • Pediatric Surgery
  • Pulmonology
  • Thoracic Surgery

Background:

  • Congenital pulmonary airway malformations (CPAMs) are typically treated with early surgical resection.
  • This recommendation is based on the assumption of compensatory lung growth in early infancy.
  • Long-term pulmonary function outcomes after CPAM lobectomy are not well-established.

Purpose of the Study:

  • To analyze the long-term pulmonary function after lobectomy for CPAM.
  • To compare pulmonary function in patients who underwent surgery before versus after one year of age.
  • To evaluate the impact of surgical timing on lung function using spirometry.

Main Methods:

  • Retrospective review of pediatric patients who underwent pulmonary lobectomy for CPAM (2001-2016).
  • Inclusion criteria: patients >5 years old capable of spirometry.
  • Patients divided into two groups: surgery before or after 12 months of age.

Main Results:

  • Twenty-three patients met inclusion criteria for spirometry.
  • Pulmonary function testing (spirometry) was performed at a mean of 9.1 years post-surgery for the early group and 4.6 years for the later group.
  • Patients undergoing lobectomy after one year of age demonstrated significantly better FEV1/FVC ratios (90% vs. 77%).

Conclusions:

  • Preliminary findings suggest that early lobectomy for CPAM may not improve long-term pulmonary function.
  • Surgical timing might influence post-lobectomy lung function, with later surgery potentially being more beneficial.
  • Further research is needed to determine the optimal age for CPAM resection.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
309
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
991
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
630